Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $100.2 million.

  • Tg Therapeutics' Treasury Shares rose 410621.07% to $100.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.2 million, marking a year-over-year increase of 410621.07%. This contributed to the annual value of $9.0 million for FY2024, which is 374358.97% up from last year.
  • Per Tg Therapeutics' latest filing, its Treasury Shares stood at $3.5 million for Q3 2025, which was down 7082.46% from $761098.0 recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Treasury Shares peaked at $12.1 million during Q3 2024, and registered a low of $41309.0 during Q1 2021.
  • In the last 5 years, Tg Therapeutics' Treasury Shares had a median value of $41309.0 in 2021 and averaged $3.1 million.
  • As far as peak fluctuations go, Tg Therapeutics' Treasury Shares changed by 0.0% in 2021, and later skyrocketed by 929829.06% in 2025.
  • Over the past 5 years, Tg Therapeutics' Treasury Shares (Quarter) stood at $234000.0 in 2021, then changed by 0.0% to $234000.0 in 2022, then changed by 0.0% to $234000.0 in 2023, then skyrocketed by 3743.59% to $9.0 million in 2024, then skyrocketed by 1014.45% to $100.2 million in 2025.
  • Its last three reported values are $100.2 million in Q3 2025, $22.0 million for Q2 2025, and $15.1 million during Q1 2025.